News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,274 Results
Type
Article (357)
Press Release (3917)
Multimedia
Podcasts (53)
Webinars (1)
Section
Business (938)
Career Advice (37)
Deals (156)
Drug Delivery (23)
Drug Development (621)
Employer Resources (9)
FDA (111)
Job Trends (49)
News (1662)
Policy (155)
Tag
Academia (16)
Allergies (2)
Alliances (259)
ALS (3)
Alzheimer's disease (15)
Antibody-drug conjugate (ADC) (1)
Approvals (107)
Artificial intelligence (3)
ASCO (3)
Autoimmune disease (2)
Automation (3)
Best Places to Work (41)
BIO (1)
Biosimilars (2)
Brain cancer (2)
Breast cancer (8)
Cancer (64)
Cardiovascular disease (6)
Career advice (40)
CAR-T (1)
CDC (1)
Cell therapy (6)
Clinical research (553)
Collaboration (13)
Compensation (1)
Complete response letters (4)
COVID-19 (24)
CRISPR (1)
C-suite (5)
Data (108)
Depression (4)
Dermatology (2)
Diabetes (3)
Diagnostics (33)
Diversity, equity & inclusion (1)
Drug discovery (5)
Drug pricing (5)
Earnings (315)
Editorial (3)
Employer resources (7)
Events (746)
Executive appointments (11)
FDA (151)
Funding (14)
Gene editing (1)
Gene therapy (7)
GLP-1 (3)
Government (28)
Guidances (1)
Healthcare (89)
Hematology (1)
Immunology and inflammation (2)
Immuno-oncology (1)
Indications (5)
Infectious disease (32)
Inflammatory bowel disease (6)
Influenza (1)
Interviews (7)
IPO (53)
Job creations (20)
Job search strategy (34)
JPM (1)
Layoffs (6)
Leadership (1)
Legal (37)
Licensing (1)
Liver cancer (1)
Longevity (1)
Lung cancer (15)
Lymphoma (2)
Management (6)
Manufacturing (4)
MASH (1)
Medical device (53)
Medtech (54)
Mergers & acquisitions (112)
Metabolic disorders (8)
mRNA (1)
Multiple sclerosis (1)
Neurodegenerative disease (4)
Neuroscience (27)
NextGen: Class of 2026 (26)
Non-profit (17)
Obesity (4)
Opinion (7)
Pain (9)
Pancreatic cancer (6)
Parkinson's disease (1)
Patents (2)
Patient recruitment (7)
People (243)
Pharmacy benefit managers (1)
Phase 1 (161)
Phase 2 (251)
Phase 3 (209)
Pipeline (98)
Policy (2)
Postmarket research (7)
Preclinical (60)
Prostate cancer (1)
Psychedelics (1)
Radiopharmaceuticals (1)
Rare diseases (13)
Real estate (27)
Recruiting (2)
Regulatory (158)
Research institute (9)
Resumes & cover letters (4)
RSV (1)
Series A (1)
Series B (2)
Sickle cell disease (3)
Special edition (1)
Startups (16)
Supply chain (2)
Tariffs (2)
The Weekly (2)
Vaccines (24)
Venture capital (2)
Weight loss (3)
Women's health (1)
Worklife (2)
Date
Last 30 days (12)
Last 365 days (188)
2026 (116)
2025 (236)
2024 (425)
2023 (371)
2022 (381)
2021 (300)
2020 (358)
2019 (224)
2018 (177)
2017 (152)
2016 (177)
2015 (207)
2014 (166)
2013 (127)
2012 (178)
2011 (127)
2010 (79)
Location
Africa (7)
Asia (141)
Australia (41)
California (43)
Canada (16)
China (11)
Colorado (2)
Connecticut (1)
Delaware (2)
Europe (719)
Florida (5)
Georgia (15)
Illinois (5)
Japan (3)
Maryland (22)
Massachusetts (17)
Michigan (2)
Minnesota (4)
Nevada (1)
New Jersey (190)
New York (97)
North Carolina (43)
Northern California (28)
Pennsylvania (6)
South America (12)
Southern California (7)
Tennessee (1)
Texas (40)
United States (466)
Utah (2)
Virginia (2)
Washington D.C. (1)
Washington State (5)
Wisconsin (1)
4,274 Results for "imidomics sl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Shattuck Labs Announces Phase 1 Results for SL-325
June 8, 2026
·
10 min read
Press Releases
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma
August 11, 2026
·
5 min read
Press Releases
Saol Therapeutics Announces the Acceptance of Resubmission of SL1009 (DCA) by the FDA with PDUFA Date of Dec. 30, 2026
July 28, 2026
·
3 min read
Press Releases
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
July 17, 2026
·
4 min read
Press Releases
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
July 10, 2026
·
5 min read
Press Releases
Saol Therapeutics Resubmits the New Drug Application for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD), an Ultra-Rare Disease
July 7, 2026
·
3 min read
Press Releases
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
June 29, 2026
·
14 min read
Press Releases
Phiusion Labs Inc. Announces Strategic Distribution Partnership with Proteos Biotech S.L. for PBSerum® in the United States and Canada
April 13, 2026
·
2 min read
Press Releases
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
June 7, 2026
·
2 min read
Press Releases
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
March 12, 2026
·
5 min read
1 of 428
Next
